Table 1.
Description of demographic and clinical characteristics of study subjects. Values are expressed as means ± standard errors of the mean (SEM)
| Idiopathic | ||||
| Control | Secondary | |||
| Low D | Normal D | |||
| Sample size | n= 30 | n= 45 | n= 22 | n= 20 |
| Age (years) | 26.93 ± 1.277 | 31.93 ± 0.7838 | 28.75 ± 1.405 | |
| Income (<300, 300-600, 600-1000, >1000) | (27%, 53%, 13%, 7%) | (16%, 73%, 7%, 4%) | (32%, 50%, 9%, 9%) | (25%, 55%, 5%, 15%) |
| Smoking (never smoked, smoker, ex-smoker) | (53%, 40%, 7%) | (38%, 51%, 11%) | (41%, 45%, 14%) | (50%, 50%, 0%) |
| Baseline vitamin D level (ng/mL) | 21.27 ± 1.729 | 12.56 ± 0.7800 | 23.55 ± 1.119 | 25.91 ± 1.415 |
| Vitamin D level after treatment (ng/mL) | - | 38.45 ± 1.464 | - | - |
| Baseline sperm concentration (million/mL) | 61.77 ± 7.538 | 20.94 ± 4.270 | 15.58 ± 2.623 | 61.05 ± 8.103 |
| Sperm concentration after treatment (million/mL) | - | 25.15 ± 4.892 | - | - |
| Baseline progressive motility (%) | 48.37 ± 2.330 | 17.80 ± 1.936 | 15.43 ± 2.644 | 45.35 ± 3.089 |
| Progressive motility after treatment (%) | - | 27.94 ± 3.533 | - | - |
| Baseline total motility (%) | 53.50 ± 2.350 | 25.40 ± 2.153 | 21.74 ± 2.874 | 52.85 ± 2.924 |
| Total motility after treatment (%) | - | 35.76 ± 3.611 | - | - |
| Baseline Morphology (%) | 14.63 ± 1.031 | 6.556 ± 0.6494 | 7.091 ± 1.374 | 20.45 ± 2.083 |
| Morphology after treatment (%) | - | 8.176 ± 0.9417 | - | - |